Get More Shots on Goal: Exploring Canada's Biotech Landscape

Thursday, October 30 2014
11:30 am – 5:30 pm

Event Inquiries

Christine Sarkisian at christine.sarkisian@international.gc.ca or Mary Beth Totten at maryelizabeth.totten@mri.gouv.qc.ca

Location: MassBio & Catalyst Restaurant, 300 Technology Square, Cambridge, MA

Join us for an unprecedented examination of the Canadian life sciences marketplace with an extraordinary group of speakers and panelists from Canada and Massachusetts.

Canada is the largest trading partner of Massachusetts and the United States.  It's also one of the top ten markets for biopharmaceutical sales in the world and exports over $5 billion in drug products annually.

MassBio, in cooperation with the Consulate General of Canada and the Quebec Government Office in Boston, presents an afternoon of networking and discussion on subject matters of use for New England companies considering Canada as a marketplace for products or as a source for collaborations or funding.

The event will begin with lunch at noon (11:30 registration) at Catalyst Restaurant and conclude with a networking reception at MassBio at 5:30 pm.

Luncheon Program at Catalyst Restaurant (Noon-1:30 PM)

Welcome - Robert Coughlin, President and CEO, MassBio

Canada's Biotech Landscape - Andrew Casey, President of BIOTECanada

Keynote Address - Pierre Meulien, President of Genome Canada

Program at MassBio 

Sources of Financing in Canada (1:45-2:30 PM)

  • Mounia Azzi, Director of Scientific Affairs, NeoMed Institute
  • Diane Gosselin, President and CEO, CQDM
  • Shermaine Tilley, CTI Life Sciences Fund
  • Gerry Brunk, Managing Director, Lumira Capital (Moderator)

Regulatory Landscape in Canada (2:30-3:15 PM)

  • Cathy Parker, Sr. Executive Director, Biologics and Genetic Therapies Directorate, Health Canada
  • Judith Atkins, PhD, Principal Consultant, Parexel
  • Robert Kulik, Principal Consultant, Patient Access Solutions
  • Gerald Quirk, Practice Group Leader, Choate Hall & Stewart, (Moderator)

What's Hot in Canadian Biotech (3:30-4:15 PM)

  • Dr. Andy Potter, Director and CEO, Vaccine and Infectious Disease Organization (VIDO)
  • Dr. Bernard Massie, Director - R&D Antibodies and Bioprocesses, National Research Council of Canada
  • Dr. Yves Joanette, Scientific Director, CIHR Institute of Aging, Canadian Institutes of health Research
  • Dr. Raju Kucherlapati, Harvard Medical School

Partnering Insights (4:15-5:30 PM)

  • Valeant Canada, Sebatien Beachamp, Executive Director, Market Access & Government Affairs
  • Johnson & Johnson Innovation Center, Dr. Thomas Luby, Senior Director
  • Zymeworks Inc., Dr. Ali Tehrani, President & CEO
  • Xagenic Inc., Ihor Boszko, Vice President, Business Development
  • VBI Vaccines, Adam Buckley, Vice President, Operations

Networking Reception (featuring Canadian beer) (5:30-7 PM)

Includes "meet and greet" stations with Canadian companies with a presence in Massachusetts: Oxalys Pharmaceuticals, Viteava Pharmaceuticals, and Algorithme Pharma

 Event Partners

Canada             Quebec

BC LogoIQOntario

Rabid Bruins, Canadiens, Maple Leafs, Oilers, Senators, Flames, Jets, and Canucks fans are all welcome, but sticks must be checked at the door.

 

Share MassBio

 

Janitronics

EvaluatePharma


 

MassBio